| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
In vivo measurement of lead in bone using x-ray fluorescence.
|
Phys Med Biol
|
1985
|
2.46
|
|
2
|
In vivo tibia lead measurements as an index of cumulative exposure in occupationally exposed subjects.
|
Br J Ind Med
|
1988
|
2.43
|
|
3
|
Partition of circulating lead between serum and red cells is different for internal and external sources of lead.
|
Am J Ind Med
|
1996
|
2.38
|
|
4
|
Unexpected mobilisation of lead during cisplatin chemotherapy.
|
Lancet
|
1986
|
1.95
|
|
5
|
Cadmium fume inhalation and emphysema.
|
Lancet
|
1988
|
1.84
|
|
6
|
In vivo measurement of liver and kidney cadmium in workers exposed to this metal: its significance with respect to cadmium in blood and urine.
|
Environ Res
|
1981
|
1.81
|
|
7
|
In vivo X-ray fluorescence of lead in bone: review and current issues.
|
Environ Health Perspect
|
1994
|
1.74
|
|
8
|
In vivo measurements of lead in bone in long-term exposed lead smelter workers.
|
Arch Environ Health
|
1993
|
1.47
|
|
9
|
In vivo measurements of bone lead--a comparison of two x-ray fluorescence techniques used at three different bone sites.
|
Phys Med Biol
|
1989
|
1.46
|
|
10
|
Monte Carlo simulation of source-excited in vivo x-ray fluorescence measurements of heavy metals.
|
Phys Med Biol
|
1998
|
1.37
|
|
11
|
In vivo measurements of lead in bone at four anatomical sites: long term occupational and consequent endogenous exposure.
|
Br J Ind Med
|
1992
|
1.37
|
|
12
|
Effect of the delta-aminolevulinate dehydratase polymorphism on the accumulation of lead in bone and blood in lead smelter workers.
|
Environ Res
|
1998
|
1.35
|
|
13
|
Comparison of two in vitro methods of bone lead analysis and the implications for in vivo measurements.
|
Phys Med Biol
|
1986
|
1.35
|
|
14
|
In vivo X-ray fluorescence of lead in bone using K X-ray excitation with 109Cd sources: radiation dosimetry studies.
|
Environ Res
|
1992
|
1.30
|
|
15
|
The reproducibility of 109Cd-based X-ray fluorescence measurements of bone lead.
|
Environ Health Perspect
|
1994
|
1.27
|
|
16
|
An improved instrument for the in vivo detection of lead in bone.
|
Br J Ind Med
|
1993
|
1.19
|
|
17
|
Accumulated body burden and endogenous release of lead in employees of a lead smelter.
|
Environ Health Perspect
|
1997
|
1.15
|
|
18
|
Effects of methandienone on the performance and body composition of men undergoing athletic training.
|
Clin Sci (Lond)
|
1981
|
1.14
|
|
19
|
Kidney effects in long term exposed lead smelter workers.
|
Br J Ind Med
|
1992
|
1.11
|
|
20
|
Repeated measurements of tibia lead concentrations by in vivo x ray fluorescence in occupational exposure.
|
Br J Ind Med
|
1992
|
1.07
|
|
21
|
Critical concentration of cadmium in renal cortex and urine.
|
Lancet
|
1979
|
1.07
|
|
22
|
Further experience with bone lead content measurements in residents of southern Ontario.
|
Appl Radiat Isot
|
1997
|
1.07
|
|
23
|
Neurotoxicity in young adults 20 years after childhood exposure to lead: the Bunker Hill experience.
|
Occup Environ Med
|
1998
|
1.06
|
|
24
|
Techniques of in vivo neutron activation analysis.
|
Phys Med Biol
|
1984
|
1.02
|
|
25
|
Ultrasound measurements of overlying soft tissue thickness at four skeletal sites suitable for in vivo x-ray fluorescence.
|
Med Phys
|
2002
|
0.98
|
|
26
|
Hormone replacement therapy may reduce the return of endogenous lead from bone to the circulation.
|
Environ Health Perspect
|
1995
|
0.98
|
|
27
|
Renal dysfunction in cadmium smelters: relation to in-vivo liver and kidney cadmium concentrations.
|
Lancet
|
1983
|
0.97
|
|
28
|
In vivo elemental analysis in occupational medicine.
|
Scand J Work Environ Health
|
1986
|
0.97
|
|
29
|
An investigation of the toxicity of gadolinium based MRI contrast agents using neutron activation analysis.
|
Magn Reson Imaging
|
2003
|
0.95
|
|
30
|
In vivo measurements of bone lead content in residents of southern Ontario.
|
Appl Radiat Isot
|
1994
|
0.94
|
|
31
|
109Cd K x ray fluorescence measurements of tibial lead content in young adults exposed to lead in early childhood.
|
Occup Environ Med
|
2000
|
0.94
|
|
32
|
Chelated lead and bone lead.
|
Scand J Work Environ Health
|
1992
|
0.93
|
|
33
|
Relations between liver cadmium, cumulative exposure, and renal function in cadmium alloy workers.
|
Br J Ind Med
|
1988
|
0.92
|
|
34
|
Factors affecting in vivo measurement precision and accuracy of 109Cd K x-ray fluorescence measurements.
|
Phys Med Biol
|
1999
|
0.88
|
|
35
|
An agreed statement on calculating lead concentration and uncertainty in XRF in vivo bone lead analysis.
|
Appl Radiat Isot
|
2003
|
0.87
|
|
36
|
Measurement of cadmium in liver and kidney using in vivo techniques.
|
Ann Occup Hyg
|
1982
|
0.86
|
|
37
|
Longitudinal studies of exposure to cadmium.
|
Br J Ind Med
|
1992
|
0.86
|
|
38
|
An improved in vivo neutron activation system for measuring kidney cadmium.
|
Phys Med Biol
|
1990
|
0.84
|
|
39
|
Measurement of whole-body nitrogen by neutron-activation analysis.
|
Lancet
|
1973
|
0.83
|
|
40
|
Hydration status assessed by multi-frequency bioimpedance analysis.
|
Appl Radiat Isot
|
1998
|
0.83
|
|
41
|
Effect of occupational lead exposure on serum 1,25-dihydroxyvitamin D levels.
|
Hum Exp Toxicol
|
1990
|
0.82
|
|
42
|
The feasibility of measuring bone uranium concentrations in vivo using source excited K x-ray fluorescence.
|
Phys Med Biol
|
1997
|
0.82
|
|
43
|
Lead concentrations in tibial and calcaneal bone in relation to the history of occupational lead exposure.
|
Scand J Work Environ Health
|
1998
|
0.81
|
|
44
|
Monitoring bone strontium levels of an osteoporotic subject due to self-administration of strontium citrate with a novel diagnostic tool, in vivo XRF: a case study.
|
Bone
|
2012
|
0.81
|
|
45
|
In vivo study of an x-ray fluorescence system to detect bone strontium non-invasively.
|
Phys Med Biol
|
2007
|
0.81
|
|
46
|
Longitudinal changes in bone lead concentration: implications for modelling of human bone lead metabolism.
|
J Environ Monit
|
2001
|
0.80
|
|
47
|
Is there any association between the presence of bone disease and cumulative exposure to lead?
|
Calcif Tissue Int
|
1998
|
0.80
|
|
48
|
The O'Flaherty model of lead kinetics: an evaluation using data from a lead smelter population.
|
Toxicol Appl Pharmacol
|
1999
|
0.80
|
|
49
|
Quantification of bone strontium levels in humans by in vivo x-ray fluorescence.
|
Med Phys
|
2004
|
0.80
|
|
50
|
An enhanced sensitivity K-shell x-ray fluorescence technique for tibial lead determination.
|
Phys Med Biol
|
1993
|
0.79
|
|
51
|
In vivo X-ray fluorescence (XRF) measurement of uranium in bone.
|
Appl Radiat Isot
|
1998
|
0.79
|
|
52
|
Improving the in vivo X-ray fluorescence (XRF) measurement of renal mercury.
|
Appl Radiat Isot
|
2000
|
0.79
|
|
53
|
Opportunities to improve the in vivo measurement of manganese in human hands.
|
Phys Med Biol
|
2008
|
0.78
|
|
54
|
Monte Carlo modelling of in vivo x-ray fluorescence of lead in the kidney.
|
Phys Med Biol
|
1991
|
0.78
|
|
55
|
An upgraded 109Cd K X-ray fluorescence bone Pb measurement.
|
Basic Life Sci
|
1993
|
0.78
|
|
56
|
Design studies related to an in vivo neutron activation analysis facility for measuring total body nitrogen.
|
Phys Med Biol
|
1992
|
0.78
|
|
57
|
Noninvasive measurement of aluminium in human bone: preliminary human study and improved system performance.
|
J Inorg Biochem
|
2009
|
0.78
|
|
58
|
Cadmium in Shipham.
|
Lancet
|
1979
|
0.78
|
|
59
|
In vivo measurement of bone aluminum in population living in southern Ontario, Canada.
|
Med Phys
|
2008
|
0.78
|
|
60
|
Design of a phantom equivalent to measure bone-fluorine in a human's hand via delayed neutron activation analysis.
|
Physiol Meas
|
2013
|
0.78
|
|
61
|
Serum (plasma) lead, blood lead, and bone lead.
|
Am J Ind Med
|
1997
|
0.77
|
|
62
|
In vivo neutron activation analysis of organ cadmium burdens. Referent levels in liver and kidney and the impact of smoking.
|
Biol Trace Elem Res
|
1991
|
0.77
|
|
63
|
Development and calibration of an in vivo bone lead measurement system, and its application to an industrially exposed population.
|
Basic Life Sci
|
1993
|
0.77
|
|
64
|
Study of the relationships between bone lead levels and its variation with time and the cumulative blood lead index, in a repeated bone lead survey.
|
J Environ Monit
|
2000
|
0.77
|
|
65
|
Quantification of manganese in human hand bones: a feasibility study.
|
Phys Med Biol
|
2008
|
0.77
|
|
66
|
A transportable system for the measurement of liver cadmium in vivo.
|
Phys Med Biol
|
1979
|
0.77
|
|
67
|
The feasibility of measuring manganese concentrations in human liver using neutron activation analysis.
|
Neurotoxicology
|
1999
|
0.76
|
|
68
|
Whole body cellular and collagen nitrogen in healthy and wasted man.
|
Clin Sci (Lond)
|
1984
|
0.76
|
|
69
|
Monte Carlo simulation of trabecular bone remodelling and absorbed dose coefficients for tritium and 14C.
|
Radiat Prot Dosimetry
|
2007
|
0.76
|
|
70
|
Measurements of fluorine in contemporary urban Canadians: a comparison of the levels found in human bone using in vivo and ex vivo neutron activation analysis.
|
Physiol Meas
|
2015
|
0.76
|
|
71
|
Birmingham Medical Research Expeditionary Society 1977 Expedition: effect of a Himalayan trek on whole body composition, nitrogen and potassium.
|
Postgrad Med J
|
1979
|
0.75
|
|
72
|
Neutron and cobalt-60 gamma irradiation produce similar changes in DNA supercoiling.
|
Radiat Res
|
1991
|
0.75
|
|
73
|
A pilot study using 99mTc to measure lead and platinum in the human kidney.
|
Nucl Med Biol
|
1993
|
0.75
|
|
74
|
Random left censoring: a second look at bone lead concentration measurements.
|
Phys Med Biol
|
2007
|
0.75
|
|
75
|
Measurement of whole body nitrogen in living man by neutron activation analysis.
|
Strahlentherapie Sonderb
|
1975
|
0.75
|
|
76
|
A feasibility study of the in vivo measurement of aluminium in peripheral bone.
|
Phys Med Biol
|
1992
|
0.75
|
|
77
|
Modeling elemental strontium in human bone based on in vivo x-ray fluorescence measurements in osteoporotic females self-supplementing with strontium citrate.
|
Physiol Meas
|
2016
|
0.75
|
|
78
|
Development of an accelerator based determination of aluminum burden in peripheral bone by neutron activation analysis.
|
Appl Radiat Isot
|
1998
|
0.75
|
|
79
|
Feasibility of measuring arsenic and selenium in human skin using in vivo x-ray fluorescence (XRF)-a comparison of methods.
|
Physiol Meas
|
2015
|
0.75
|
|
80
|
System design for in vivo neutron activation analysis measurements of manganese in the human brain: based on Monte Carlo modeling.
|
Appl Radiat Isot
|
2000
|
0.75
|
|
81
|
In vivo neutron activation analysis measurements of calcium using the 40Ca(n, alpha) 37Ar reaction.
|
Int J Appl Radiat Isot
|
1976
|
0.75
|
|
82
|
On the in vivo measurement of mercury using neutron capture and x-ray fluorescence.
|
Int J Appl Radiat Isot
|
1982
|
0.75
|
|
83
|
Gadolinium detection via in vivo prompt gamma neutron activation analysis following gadolinium-based contrast agent injection: a pilot study in 10 human participants.
|
Physiol Meas
|
2014
|
0.75
|
|
84
|
Ex vivo evaluation of a coherent normalization procedure to quantify in vivo finger strontium XRS measurements.
|
Med Phys
|
2012
|
0.75
|
|
85
|
In vivo prompt gamma neutron activation analysis of cadmium in the kidney and liver.
|
Appl Radiat Isot
|
2005
|
0.75
|
|
86
|
Calibration of (109)Cd KXRF systems for in vivo bone lead measurements: the guiding role of the assumptions for least-squares regression in practical problem solving.
|
Phys Med Biol
|
2009
|
0.75
|
|
87
|
The feasibility of in vivo quantification of bone-fluorine in humans by delayed neutron activation analysis: a pilot study.
|
Physiol Meas
|
2012
|
0.75
|
|
88
|
Characteristics of an accelerator based system for in vivo aluminium measurement in peripheral bone.
|
Basic Life Sci
|
1993
|
0.75
|
|
89
|
In vivo assessment of magnesium status in human body using accelerator-based neutron activation measurement of hands: a pilot study.
|
Med Phys
|
2008
|
0.75
|
|
90
|
A preliminary study for non-invasive quantification of manganese in human hand bones.
|
Phys Med Biol
|
2008
|
0.75
|
|
91
|
Gamma ray nuclear resonance absorption: an alternative method for in vivo body composition studies.
|
Ann N Y Acad Sci
|
2000
|
0.75
|
|
92
|
Coherent normalization of finger strontium XRF measurements: feasibility and limitations.
|
Phys Med Biol
|
2008
|
0.75
|
|
93
|
Dosimetric characterization of the irradiation cavity for accelerator-based in vivo neutron activation analysis.
|
Phys Med Biol
|
2007
|
0.75
|
|
94
|
The feasibility of in vivo detection of gadolinium by prompt gamma neutron activation analysis following gadolinium-based contrast-enhanced MRI.
|
Appl Radiat Isot
|
2010
|
0.75
|
|
95
|
The use of multiple parameters to characterize cadmium-induced renal dysfunction resulting from occupational exposure.
|
Environ Res
|
1994
|
0.75
|
|
96
|
An accelerator based system for in vivo neutron activation analysis measurements of manganese in human hand bones.
|
Med Phys
|
2002
|
0.75
|
|
97
|
Pilot studies for in vivo bone aluminum measurements.
|
Basic Life Sci
|
1993
|
0.75
|
|
98
|
Monte Carlo design study for in vivo bone aluminum measurement using a low energy accelerator beam.
|
Appl Radiat Isot
|
2000
|
0.75
|
|
99
|
In vivo measurement of calcium by the 37Ar method: a study of the effect of recirculating breath collection systems on the exhalation rate.
|
Phys Med Biol
|
1978
|
0.75
|
|
100
|
Improvements to the in vivo measurement of cadmium in the kidney by neutron activation analysis.
|
Appl Radiat Isot
|
1998
|
0.75
|
|
101
|
Feasibility studies in the in vivo measurement of iron in synovial membrane.
|
Basic Life Sci
|
1990
|
0.75
|
|
102
|
Calibration of (109)Cd KXRF systems for in vivo bone lead measurements: weighted least-squares regression with different weighting functions.
|
Phys Med Biol
|
2009
|
0.75
|
|
103
|
Improvements in an in vivo neutron activation analysis (NAA) method for the measurement of fluorine in human bone.
|
Physiol Meas
|
2013
|
0.75
|
|
104
|
Lead post-mortem intake in human bones of ancient populations by (109)Cd-based X-ray fluorescence and EDXRF.
|
Talanta
|
2006
|
0.75
|
|
105
|
A transportable system for measurement of kidney cadmium in vivo.
|
Int J Appl Radiat Isot
|
1981
|
0.75
|
|
106
|
A feasibility study to determine the potential of in vivo detection of gadolinium by x-ray fluorescence (XRF) following gadolinium-based contrast-enhanced MRI.
|
Physiol Meas
|
2014
|
0.75
|
|
107
|
Low energy component of the spectra of fast neutron beams in clinical use.
|
Phys Med Biol
|
1979
|
0.75
|
|
108
|
Evaluation of imaging technologies to correct for photon attenuation in the overlying tissue for in vivo bone strontium measurements.
|
Phys Med Biol
|
2010
|
0.75
|
|
109
|
Problems in the interpretation of the in vivo measurement of calcium by the argon-37 method: an investigation of inert-gas elimination in humans.
|
J Nucl Med
|
1978
|
0.75
|
|
110
|
Normalisation with coherent scatter signal: improvements in the calibration procedure of the 57Co-based in vivo XRF bone-Pb measurement.
|
Appl Radiat Isot
|
2001
|
0.75
|
|
111
|
In vivo measurement of bone aluminium: recent developments.
|
J Inorg Biochem
|
2005
|
0.75
|
|
112
|
A 238Pu/Be facility for in vivo cadmium measurements.
|
Basic Life Sci
|
1993
|
0.75
|
|
113
|
Age and sex influence on bone and blood lead concentrations in a cohort of the general population living in Toronto.
|
Physiol Meas
|
2017
|
0.75
|
|
114
|
Performance appraisals of digital spectroscopy systems for the measurement of bone lead.
|
Appl Radiat Isot
|
2000
|
0.75
|
|
115
|
Feasibility of measuring selenium in humans using in vivo neutron activation analysis.
|
Physiol Meas
|
2015
|
0.75
|
|
116
|
In vivo neutron activation study of the short-term kinetic behaviour of sodium and chlorine in the human hand.
|
Physiol Meas
|
2016
|
0.75
|
|
117
|
Coherent normalization for <i>in vivo</i> measurements of gadolinium in bone.
|
Physiol Meas
|
2017
|
0.75
|